fda banning tirzepatide says years-long shortage is resolved, will give limited leeway to compounders Compounded GLP-1 Statistics 2026 |

For athletic testing, lack of therapeutic use exemption documentation means the substance violation stands regardless of intent

Learn more about how Quality is at the Center of Everything We Do

Additive GI burden: Nausea, vomiting, and diarrhea are dose-dependent, GLP-1-mediated effects

So if you absolutely have to use it because a patients INR is 11 (even if theyre not clinically bleeding) or a patients INR is 4 and theyre having nosebleeds, use as small of a dose as possible to get the patient back in a safe range and mitigate the bleeding

In addition, B12 deficiency is associated with weakness in the limbs and impaired cognitive functions